Evaluation of Adverse Drug Event Information in US Manufacturer Labels

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|6|1|30-35

ISSN： 1574-8863

Source： Current Drug Safety, Vol.6, Iss.1, 2011-02, pp. : 30-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of a Swiss adverse drug event prevention collaborative

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 21, Iss. 4, 2015-08 ,pp. : 717-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 285-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS)

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 9, 2015-09 ,pp. : 922-933

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medication Event Huddles: A Tool for Reducing Adverse Drug Events

By Morvay Shelly   Lewe Dorcas   Stewart Barbara   Catt Charline   McClead   Jr Richard E.   Brilli Richard J.  

Joint Commission Journal on Quality and Patient Safety, Vol. 40, Iss. 1, 2014-01 ,pp. : 39-0

Joint Commission Resources

Access to resources Recommend Favorite

The Response to an Adverse Drug Event: Complying with Standard MM.6.20

By  

Joint Commission: The Source, Vol. 6, Iss. 6, 2008-06 ,pp. : 4-10

Joint Commission Resources

Access to resources Recommend Favorite